Project Oncology®

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.

Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

256

LikeLikedUnlike

Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Project Oncology®
Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
- Jennifer Caudle, DO, FACOFP
- Ida Micaily, MD
- Jeffrey Varanelli, OD
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Medical Industry Feature
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
- Charles Turck, PharmD, BCPS, BCCCP
- Sarah Sammons, MD
Advancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us
Medical Industry Feature
Advancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us
- Jennifer Caudle, DO, FACOFP
- Seth Wander, MD, PhD
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Project Oncology®
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
- Charles Turck, PharmD, BCPS, BCCCP
- Jun Gong, MD
Early CAR T Cell Therapy Referral: The Missing Piece in Blood Cancer Treatment
Project Oncology®
Early CAR T Cell Therapy Referral: The Missing Piece in Blood Cancer Treatment
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Project Oncology®
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
- Charles Turck, PharmD, BCPS, BCCCP
- Jaffer Ajani, MD
advertisement

6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
Project Oncology®
6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
- Steve Jackson, PharmD
- Lyudmila A. Bazhenova, MD
Assessing and Interpreting pCR in Perioperative NSCLC
Project Oncology®
Assessing and Interpreting pCR in Perioperative NSCLC
- Steve Jackson, PharmD
- Alexander Spira, MD, PhD, FACP
Decoding epNECs: Diagnostic Challenges and Emerging Strategies
Project Oncology®
Decoding epNECs: Diagnostic Challenges and Emerging Strategies
- Brian P. McDonough, MD, FAAFP
- Andrew E. Hendifar, MD
Navigating Classification of High-Grade Neuroendocrine Neoplasms
Project Oncology®
Navigating Classification of High-Grade Neuroendocrine Neoplasms
- Charles Turck, PharmD, BCPS, BCCCP
- Rohit Thummalapalli, MD
Key Differences in Pulmonary and Extrapulmonary NEC Management
Project Oncology®
Key Differences in Pulmonary and Extrapulmonary NEC Management
- Alexandria May, PharmD, BCPS
- Lowell B. Anthony, MD, FACP
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Project Oncology®
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
- Charles Turck, PharmD, BCPS, BCCCP
- Rohit Thummalapalli, MD
advertisement

Dialogue with the Experts: Best Practices in NSCLC
CME/CE
Dialogue with the Experts: Best Practices in NSCLC
- James "Tate" Thigpen, MD
- Kristi Orbaugh, MSN, RNP, AOCN